Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Monika, Czaplińska"'
Autor:
Monika Czaplińska, Agnieszka Ćwiklińska, Monika Sakowicz-Burkiewicz, Ewa Wieczorek, Agnieszka Kuchta, Robert Kowalski, Barbara Kortas-Stempak, Alicja Dębska-Ślizień, Maciej Jankowski, Ewa Król
Publikováno v:
Lipids in Health and Disease, Vol 18, Iss 1, Pp 1-9 (2019)
Abstract Background Chronic kidney disease (CKD) associates with complex lipoprotein disturbances resulting in high cardiovascular risk. Apolipoprotein E (APOE) is a polymorphic protein with three common isoforms (E2; E3; E4) that plays a crucial rol
Externí odkaz:
https://doaj.org/article/faad659496654035add03975f9b5dbef
Autor:
Michał Chmielewski, Sylwia Małgorzewicz, Monika Czaplińska, Alicja Debska-Slizien, Adriana Mika, Malgorzata Sikorska-Wisniewska, Tomasz Sledzinski
Publikováno v:
Transplantation Proceedings. 52:2324-2330
Background Disturbances in polyunsaturated fatty acids (PUFA) could predispose renal transplant (RTx) patients to cardiovascular risk. The purpose of this study was to evaluate serum content of ω-3 and ω-6 PUFA in RTx subjects, in comparison to non
Autor:
Anna Gliwińska, Agnieszka Ćwiklińska, Monika Czaplińska, Ewa Wieczorek-Breitzke, Barbara Kortas-Stempak, Agnieszka Kuchta, Alicja Dębska-Ślizień, Ewa Król, Maciej Jankowski
Publikováno v:
Journal of nephrology.
Background High-density lipoprotein (HDL) is a heterogeneous group of particles with anti-atherogenic properties whose metabolism is alterated in chronic kidney disease (CKD). The aim of this study was to evaluate the particle size and mobility of HD
Autor:
Ewa Król, Karolina Dorniak, Alicja Dębska-Ślizień, Monika Czaplińska, Sławomir Lizakowski, Adam Grzybowski
Publikováno v:
Polish Archives of Internal Medicine.
Autor:
Agnieszka Kuchta, Monika Czaplińska, Marta Marcinkowska, Barbara Kortas-Stempak, Agnieszka Ćwiklińska, Ewa Wieczorek, Alicja Dębska-Ślizień, Anna Gliwińska, Ewa Król, Maciej Jankowski, Marcin Gruchała, Agnieszka Mickiewicz
Publikováno v:
Clinical chemistry and laboratory medicineReferences. 59(5)
Objectives Low-density lipoprotein cholesterol (LDL-C) is the main laboratory parameter used for the management of cardiovascular disease. The aim of this study was to compare measured LDL-C with LDL-C as calculated by the Friedewald, Martin/Hopkins,
Autor:
Michał, Chmielewski, Justyna, Korczyńska, Maciej, Śledziński, Monika, Czaplińska, Alicja, Dębska-Ślizień, Adriana, Mika
Publikováno v:
Polish archives of internal medicine. 129(9)
Autor:
Alicja Dębska-Ślizień, Monika Czaplińska, Maciej Śledziński, Adriana Mika, Michał Chmielewski, Justyna Korczynska
Publikováno v:
Polish Archives of Internal Medicine.
Autor:
Ewa Król, Anna Gliwińska, Barbara Kortas-Stempak, Agnieszka Mickiewicz, Kamil Dąbkowski, Agnieszka Kuchta, Ewa Wieczorek, Alicja Dębska-Ślizień, Agnieszka Ćwiklińska, Kornelia Sałaga-Zaleska, Maciej Jankowski, Monika Czaplińska
Publikováno v:
International Journal of Molecular Sciences
International Journal of Molecular Sciences, Vol 20, Iss 5, p 1202 (2019)
Volume 20
Issue 5
International Journal of Molecular Sciences, Vol 20, Iss 5, p 1202 (2019)
Volume 20
Issue 5
In chronic kidney disease (CKD), the level of high-density lipoprotein (HDL) decreases markedly, but there is no strong inverse relationship between HDL-cholesterol (HDL-C) and cardiovascular diseases. This indicates that not only the HDL-C level, bu
Autor:
Barbara Kortas-Stempak, Maciej Jankowski, Agnieszka Ćwiklińska, Monika Czaplińska, Monika Sakowicz-Burkiewicz, Robert Kowalski, Ewa Król, Ewa Wieczorek, Alicja Dębska-Ślizień, Agnieszka Kuchta
Publikováno v:
Lipids in Health and Disease
Lipids in Health and Disease, Vol 18, Iss 1, Pp 1-9 (2019)
Lipids in Health and Disease, Vol 18, Iss 1, Pp 1-9 (2019)
Background Chronic kidney disease (CKD) associates with complex lipoprotein disturbances resulting in high cardiovascular risk. Apolipoprotein E (APOE) is a polymorphic protein with three common isoforms (E2; E3; E4) that plays a crucial role in lipo